InsidersTradesSigma
Follow the Seaport Therapeutics, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on US US, under the authority of SEC (Form 4). The latest transaction was disclosed on 24 June 2026 (Acquisition). Among the most active insiders: HOMBACH ROBERT J.. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Seaport Therapeutics, Inc. is a company focused on developing innovative therapies. It specializes in the research and commercialization of treatments for serious diseases.